An expanding volume of patient care activity, spurred by aging demographic patterns, a rising incidence of diseases and disorders, and the extension of health insurance coverage by the Affordable Care Act of 2010, will create a large demand for in vitro (IVD) diagnostic products in the United States.
The sector is predicted to increase 6.1% annually to $24.7 billion in 2016, according to a new study from the The Freedonia Group, Inc. ...
More